Watch SHC. Know when insiders buy.
One email the day a filing lands. Free.
SHC
Sotera Health Co
18.31
−0.03 −0.16%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
53
WATCH · shorts 53
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $5.2BP/E 32.1DIV YIELD —FCF YIELD 2.16%REV TTM $1.2B +8.1%NET INCOME $163.5M +580.5%NET DEBT $1.8B52W 13.13 – 19.57SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $321.4M | +9.2% | 55.4% | — | $53.6M | +573.7% | 0.19 | $88.5M | $46.4M | $42M | Aug 6 |
| Q1 2026 · Mar 31 | $280M | +10.0% | 52.5% | — | $26.6M | — | 0.09 | $29.4M | $46.2M | −$16.7M | May 5 |
| Q4 2025 · Dec 31derived | $303.4M | +4.6% | 54.7% | — | $34.8M | +182.8% | 0.12 | $103.1M | $50.7M | $52.4M | Feb 24 |
| Q3 2025 · Sep 30 | $311.3M | +9.1% | 57.0% | — | $48.4M | +184.7% | 0.17 | $71.2M | $36.2M | $35M | Nov 4 |
| Q2 2025 · Jun 30 | $294.3M | +6.4% | 56.6% | — | $8M | −9.0% | 0.03 | $57.4M | $31.2M | $26.2M | Aug 6 |
| Q1 2025 · Mar 31 | $254.5M | +2.6% | 53.2% | — | −$13.3M | −309.7% | -0.05 | $55.5M | $19.9M | $35.6M | May 5 |
| Q4 2024 · Dec 31derived | $290.2M | −6.5% | 56.6% | $87.1M | $12.3M | −68.1% | 0.05 | $55.7M | $65.9M | −$10.2M | Feb 24 |
| Q3 2024 · Sep 30 | $285.5M | +8.5% | 55.4% | $80.5M | $17M | — | 0.06 | $97.5M | $36.4M | $61.1M | Nov 4 |
| Q2 2024 · Jun 30 | $276.6M | — | 55.2% | $76.8M | $8.8M | — | 0.03 | $61.3M | $41.9M | $19.4M | Aug 8 |
| Q1 2024 · Mar 31 | $248.2M | — | 51.2% | $53.2M | $6.3M | — | 0.02 | $9.7M | $34.9M | −$25.2M | May 1 |
| Q4 2023 · Dec 31derived | $310.2M | — | 58.0% | $104M | $38.7M | — | 0.14 | $113.1M | $64.8M | $48.3M | Feb 24 |
| Q3 2023 · Sep 30 | $263.2M | — | 55.5% | $76.1M | −$13.7M | — | -0.05 | $41.8M | $52M | −$10.2M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.2B | 55.5% | — | $77.9M | 6.7% | 0.27 | $287.2M | $138M | $149.2M | — | — |
| FY2024 · to Dec 31 | $1.1B | 54.7% | $297.6M | $44.4M | 4.0% | 0.16 | $224.2M | $179.1M | $45.1M | — | — |
| FY2023 · to Dec 31 | $1B | 55.0% | $276.7M | $51.4M | 4.9% | 0.18 | −$147.7M | $215M | −$362.7M | — | — |
| FY2022 · to Dec 31 | $1B | 55.5% | $248.3M | −$233.6M | -23.3% | -0.83 | $278M | $182.4M | $95.6M | $0 | — |
| FY2021 · to Dec 31 | $931.5M | 55.7% | $256.7M | $116.9M | 12.5% | 0.41 | $281.5M | $102.2M | $179.4M | $0 | $0 |
| FY2020 · to Dec 31 | $818.2M | 54.2% | $206M | −$38.6M | -4.7% | -0.16 | $120.6M | $53.5M | $67.1M | $34M | $0 |
Every number comes from Sotera Health Co's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.